TAB008 Compared to Avastin® in Patients With EGFR Wild-type Non-squamous Non-small Cell Lung Cancer
Clinical trial NCT05427305 · COMPLETED
Trial details
- NCT number
- NCT05427305
- Sponsor
- BioDlink Biopharm Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-20
- Primary completion
- 2020-03-24
- Enrollment
- 549
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.